Companies & Industry »Company News»Company News Details
Company News Details

BSE   06 Oct 15 | 12:00 AM

425.10 9.04 (2.17%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   06 Oct 15 | 12:00 AM

425.65 9.41 (2.26%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 2,061.65 (-79.38%)
1 Month : Rs 1,817.05 (-76.60%)
1 Year : Rs 1,308.10 (-67.50%)
change companytradenow

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."


Company Price Gain (%)
Tata Motors333.505.81
Coal India342.754.02
GAIL (India)307.953.17

Online Portfolio

You can create Online Portfolio here using the below button.